Pathfinders in Biopharma

Perspectives from the cutting edge of biotech and pharma.

Author: RBC Capital Markets

Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
Be a guest on this podcast

Language: en

Genres: Business, Business News, Investing, News

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it

Get all podcast data

Listen Now...

MindMed: Rethinking brain health with psychedelic therapy
Episode 33
Wednesday, 17 September, 2025

Over the last 18 months, MindMed has undergone an extraordinary transformation. It released compelling data for its LSD-based drug MM120, followed by FDA breakthrough designation for MM120 for the treatment of GAD, and strong financial backing. CEO Rob Barrow outlines the company's ambitious goals and the path to potentially transforming mental healthcare at RBC's Global Healthcare Conference.